Geneus - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $93,443.89 -2.32%
Ethereum $3,347.16 +0.65%
BNB $683.51 +3.92%
Optimism $1.83 +2.31%
Arbitrum $0.77 +2.26%
Solana $184.78 +1.18%
Polygon $0.48 +0.41%
Cosmos $6.60 +0.67%
Avalanche $37.05 -1.28%

Bitcoin $93,443.89 -2.32%
Ethereum $3,347.16 +0.65%
BNB $683.51 +3.92%
Optimism $1.83 +2.31%
Arbitrum $0.77 +2.26%
Solana $184.78 +1.18%
Polygon $0.48 +0.41%
Cosmos $6.60 +0.67%
Avalanche $37.05 -1.28%

Geneus

company

Summary
Funding Rounds
Investors

About

Geneus is a developer of gene sequencers and reagents.

51 - 100

Highlights

Details

Last Funding Type: Series B
Industries: Biotechnology
Founded date: Apr 1, 2017
Number Of Employee: 51 - 100
Operating Status: Active

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

—

Geneus has raised a total of — in funding over 2 rounds. Their latest funding was raised on Sep 28, 2021 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Sep 28, 2021	Series B	—	2	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

—

2

Geneus is funded by 2 investors. Darun Touzi and Rays Venture Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
Darun Touzi	—	Series B
Rays Venture Capital	—	Series B